<DOC>
	<DOCNO>NCT02124278</DOCNO>
	<brief_summary>The purpose determine single dose PUL-042 inhalation solution safe healthy subject .</brief_summary>
	<brief_title>Safety Tolerability Single Ascending Doses PUL-042 Inhalation Solution Healthy Subjects</brief_title>
	<detailed_description>The study ass safety , tolerability , pharmacokinetics pharmacodynamics single ascend dos PUL-042 inhalation solution healthy subject . Subjects enter screen period 14 day determine eligibility . Subjects admit Phase 1 unit day prior dose remain unit 24 hour post-dose . Subjects see clinic 3 7 day post-dose A modify 3+3 design use determine maximum tolerate dose ( MTD ) base occurrence dose-limiting toxicity ( DLTs ) define Common Terminology Criteria Adverse Events ( CTCAE ) v4 . Additional specific DLTs define : 1 ) Hypoxia , define non-artifactual drop pulse oximetry &lt; 90 % room air , 2 ) A decrease forced expiratory volume one second ( FEV1 ) 12 % great compare last observation prior dose , 3 ) Any evidence bronchospasm wheeze require medical intervention . Doses doubled maximum tolerate dose ( MTD- define large dose 0/6 1/6 DLTs ) reach .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Males female nonchildbearing potential Body mass index 18 30 kg/m2 Normal spirometry Normal diffusing capacity lung carbon monoxide Normal pulse oximetry Males willing practice contraception female partner use contraception Febrile Abnormal chest xray History tobacco product within last year total exposure &gt; 5 pack/years Clinically significant laboratory finding History chronic pulmonary disease History atopic reaction Mediastinal lymphadenopathy Oral corticosteroid therapy within 4 week prior randomization Alcohol , caffeine strenuous exercise within 72 hour prior dose Grapefruit within 7 day prior dose Administration concomitant medication within 14 day prior dose Exposure investigational agent 30 day Significant concurrent illness Know positive HIV , hepatitis B hepatitis C Inability tolerate nebulization test sterile water injection Positive test drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Single ascend dose</keyword>
	<keyword>Safety tolerability healthy subject</keyword>
</DOC>